Ftse Mib
34.519,17
-0,88%
DAX
18.666,82
-0,53%
S&P 500
5.308,13
0,00%
NASDAQ
16.794,87
0,00%
Bitcoin
71.164,63
-0,40%

Quotazioni in diretta

Non abbiamo trovato risultati per:
Assicurati di aver scritto correttamente o prova ad allargare la ricerca.

Più Attivi

Toplist

Sembra che tu non sia connesso.
Clicca il pulsante qui sotto per accedere e visualizzare la tua cronologia recente.

Registrati

Sei già registrato? Accedi

Pepperstone

Inizia Ora

Pepperstone
Home Investire Azioni U.S.A. NASDAQ MIRA Pharmaceuticals Inc (MIRA) MIRA Pharmaceuticals Inc (MIRA) Notizie

MIRA Pharmaceuticals Inc

MIRA
0,862
0,012 (1,41%)
Pre Mercato
Ultimo aggiornamento: 14:09:35
Dati in Delay di 15 minuti
Borsa: NASDAQ
Tipo: Azione
Valuta: USD

Ultime notizie

Data Ora Fonte Titolo
20/5/202414:00PRNUSMira Pharmaceuticals Advances Preclinical Trials Towards an..
13/5/202422:31EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
02/4/202414:00PRNUSMira Pharmaceuticals Announces Encouraging Preclinical..
21/3/202416:04PRNUSMIRA Pharmaceuticals Welcomes Dr. Itzchak Angel, former Head..
07/3/202422:45EDGAR2Form 8-K - Current report
05/2/202414:30PRNUSMIRA Pharmaceuticals Provides Corporate Update
17/1/202422:30EDGAR2Form 8-K - Current report
28/12/202306:15EDGAR2Form EFFECT - Notice of Effectiveness
27/12/202323:33EDGAR2Form 4 - Statement of changes in beneficial ownership of..
27/12/202323:27EDGAR2Form SC 13D/A - General statement of acquisition of..
18/12/202322:50EDGAR2Form S-1 - General form for registration of securities under..
04/12/202314:00PRNUSMIRA Pharmaceuticals Releases Breakthrough Data from..
01/12/202323:00EDGAR2Form 8-K - Current report
29/11/202314:00PRNUSMIRA Pharmaceuticals Announces Ketamir-2's Oral..
21/11/202316:42PRNUSMIRA Pharmaceuticals To Host Shareholder Update Call on..
21/11/202316:09PRNUSMIRA Pharmaceuticals Announces Paradigm-Shift in Cognitive..
20/11/202322:18EDGAR2Form SC 13D/A - General statement of acquisition of..
20/11/202322:15EDGAR2Form 3 - Initial statement of beneficial ownership of..
20/11/202314:10EDGAR2Form 8-K - Current report
20/11/202314:00PRNUSMIRA Pharmaceuticals Announces Exclusive Licensing Agreement..
18/9/202314:30PRNUSMIRA Pharmaceuticals Shows its Prescription Pill More..
05/9/202314:31PRNUSMIRA Pharmaceuticals and MZ Group Partner to Strengthen..
31/8/202314:31PRNUSMIRA Pharmaceuticals to Participate in 6th Annual..
29/8/202317:39PRNUSMIRA Pharmaceuticals to Host Virtual Roadshow Webinar on..
Apertura: Min: Max:
Chiusura: 0,85

La tua Cronologia

NASDAQ
MIRA
MIRA Pharmaceuticals
EU
VEVAT
Suez SA 2.875% Perpetual...
ASX
FXEKOR
EU
AVTX
Avantium NV
LSE
FUJ
NYSE
BHR
Braemar Hotels and Resorts
Delayed Upgrade Clock

Il sito ADVFN Italia è stato realizzato ed è gestito da PRODESFIN su licenza di ADVFN PLC.

PER CONTATTI E PUBBLICITA' CLICCA QUI

Accedendo ai servizi offerti da ADVFN, ne si accettano le condizioni generali Termini & Condizioni

ADVFN Network